SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +9 vs. Q3 2023
- Shares held
- 35.6M
- +32.3M (+973.1%) vs. Q3 2023
- Total value
- $24.5M
- +$22.4M (+1,069.5%) vs. Q3 2023
- New holders
- 14
- 6 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 68 | $0 | 0.00% | −5,026−98.7% | Reduced |
| Bank of America Corp | 54 | $38 | 0.00% | +54 | New |
| Qube Research & Technologies Ltd | 69 | $47 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 145 | $100 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 294 | $202 | 0.00% | +26+9.7% | Added |
| FMR LLC | 343 | $236 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $344 | 0.00% | +500 | New |
| JPMorgan Chase & Co | 951 | $654 | 0.00% | +24+2.6% | Added |
| Gs Investments, Inc. | 2,000 | $1.38K | 0.00% | 00.0% | Unchanged |
| LM Advisors LLC | 3,620 | $2.49K | 0.00% | +3,620 | New |
| Spectrum Wealth Counsel, LLC | 5,030 | $3.46K | 0.00% | +5,030 | New |
| Elgethun Capital Management | 5,435 | $6.47K | 0.00% | −4,500−45.3% | Reduced |
| 1st Source Bank | 10,000 | $6.88K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $6.88K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11,506 | $7.91K | 0.00% | −3,900−25.3% | Reduced |
| Commonwealth Equity Services, LLC | 12,823 | $9.00K | 0.00% | +12,823 | New |
| Nadler Financial Group, Inc. | 13,750 | $9.45K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,235 | $10.5K | 0.00% | +295+2.0% | Added |
| Charles Schwab Investment Management Inc | 16,238 | $11.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,719 | $11.5K | 0.00% | +16,719 | New |
| Northern Trust Corp | 44,476 | $30.6K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 46,373 | $31.9K | 0.00% | −300−0.6% | Reduced |
| Creative Planning | 47,518 | $32.7K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,891 | $35.7K | 0.00% | +51,891 | New |
| Peapack Gladstone Financial Corp | 52,296 | $36.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 52,643 | $36.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 63,100 | $43.0K | 0.00% | +5,000+8.6% | Added |
| Mariner, LLC | 69,000 | $47.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $55.9K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 88,000 | $60.5K | 0.00% | +67,000+319.0% | Added |
| Institutional & Family Asset Management, LLC | 192,027 | $132.0K | 0.02% | 00.0% | Unchanged |
| First Manhattan Co | 277,777 | $191.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 356,364 | $245.1K | 0.00% | 00.0% | Unchanged |
| Pathstone Holdings, LLC | 506,513 | $348.2K | 0.00% | +506,513 | New |
| First PREMIER Bank | 807,535 | $555.0K | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 996,132 | $684.8K | 0.00% | +19,194+2.0% | Added |
| Commodore Capital LP | 1,831,746 | $1.26M | 0.11% | +1,831,746 | New |
| Ra Capital Management, L.P. | 2,374,081 | $1.63M | 0.03% | +2,374,081 | New |
| Sessa Capital IM, L.P. | 4,584,571 | $3.15M | 0.15% | +4,584,571 | New |
| Marshall Wace, LLP | 4,585,282 | $3.16M | 0.01% | +4,585,282 | New |
| BVF Inc | 9,178,282 | $6.31M | 0.16% | +9,178,282 | New |
| RTW Investments, LP | 9,178,282 | $6.31M | 0.10% | +9,178,282 | New |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −73,470−100.0% | Sold out |
| Brookstone Capital Management | 0 | $0 | 0.00% | −21,755−100.0% | Sold out |
| LGL Partners, LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Strategic Financial Concepts, LLC | 0 | $0 | 0.00% | −15,027−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |